| BCBS Highmark NY and West NY | Anifrolumab-fnia (Saphnelo) | 2026-08-31 |
| BCBS Highmark Delaware | Administrative Policy: Evolent Policies | 2026-08-31 |
| BCBS Highmark Delaware | Intravitreal Injections | 2026-08-31 |
| BCBS Highmark Delaware | Anifrolumab-fnia (Saphnelo) | 2026-08-31 |
| BCBS Highmark Delaware | Granulocyte Colony-Stimulating Factors | 2026-08-31 |
| BCBS Highmark NY and West NY | Lumasiran (Oxlumo) | 2026-08-31 |
| BCBS Highmark Delaware | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-08-31 |
| BCBS Highmark Delaware | Bevacizumab-tnjn (Avizi) | 2026-08-31 |
| BCBS Highmark West Virginia | Administrative Policy: Evolent Policies | 2026-08-31 |
| BCBS Highmark West Virginia | Granulocyte Colony-Stimulating Factors | 2026-08-31 |